{"organizations": [], "uuid": "9119a1963a0206c10dbde54d6a19a05364208d20", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/11", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/26/globe-newswire-vital-therapies-announces-upcoming-first-quarter-financial-results-conference-call-with-webcast.html", "country": "US", "domain_rank": 767, "title": "Vital Therapies Announces Upcoming Financial Conference Call with Webcast", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.113, "site_type": "news", "published": "2018-04-27T00:05:00.000+03:00", "replies_count": 0, "uuid": "9119a1963a0206c10dbde54d6a19a05364208d20"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/26/globe-newswire-vital-therapies-announces-upcoming-first-quarter-financial-results-conference-call-with-webcast.html", "ord_in_thread": 0, "title": "Vital Therapies Announces Upcoming Financial Conference Call with Webcast", "locations": [], "entities": {"persons": [], "locations": [{"name": "webcast san diego", "sentiment": "none"}], "organizations": [{"name": "company", "sentiment": "none"}, {"name": "elad", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its first quarter 2018 financial results after the market closes on Tuesday, May 8, 2018 followed by a conference call at 4:30 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the Company will review financial results and discuss other business matters.\nThe conference call dial-in numbers are (855) 765-5682 for domestic callers and (919) 825-3204 for international callers. The conference ID number for the call is 5845687. Participants may access the live webcast via a link on the Vital Therapies website in the Investors Relations section under Events at: http://ir.vitaltherapies.com/ . The webcast will be archived on the Company's website shortly after completion of the call.\nFor those unable to listen in at the designated time, a conference call replay will be available for one week following the conference call, from approximately 7:30 p.m. ET on May 8, 2018 to 7:30 p.m. ET on May 15, 2018. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 5845687.\nAbout Vital Therapies, Inc.\nVital Therapies, Inc. is a biotherapeutic company developing a cell-based therapy targeting the treatment of acute forms of liver failure. The Company's ELAD System is an extracorporeal human allogeneic cellular liver therapy currently in phase 3 clinical trials. Vital Therapies, Inc. is based in San Diego, California. Vital Therapies® and ELAD® are trademarks of Vital Therapies, Inc.\nContact:\nVital Therapies, Inc.\nAl Kildani\nVice President, Investor Relations and Business Development\n858-673-6840\nakildani@vitaltherapies.com\nSource:Vital Therapies, Inc.", "external_links": ["https://www.globenewswire.com/Tracker?data=Omt5YxSVemzhfXY7amq1hkQOaayg7h63Ct4lgflYYt6R9XJ-mVL0W-XoR-fDNWDTGSrUwWEsh9kZLcCceDXVqcRlh_hVqPFrCS94XhAvusBESgwR6eAYh3HXdgyO7ejw", "https://www.globenewswire.com/NewsRoom/AttachmentNg/27dd26df-cb68-4a6f-b782-dc59e48795ea", "http://ir.vitaltherapies.com/", "https://www.globenewswire.com/Tracker?data=fFTLyMz4E51lCRcP7e7T3ExEtLmKQCUgwOdVDv94XtAPGfEA5vIXPNpH4laR_5z3Hx_WnS9g-GvNb4InRnhlM7X1EiSXEfjBBBct2v4WfUY="], "published": "2018-04-27T00:05:00.000+03:00", "crawled": "2018-04-27T00:56:56.040+03:00", "highlightTitle": ""}